Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysisReisa A. Sperling, Michael Grundman, Stephen Salloway et al.|The Lancet Neurology|2012Cited by 510
First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ DysfunctionMorie A. Gertz, Michaela Liedtke, Heather Landau et al.|Journal of Clinical Oncology|2016Cited by 206
Solution State Characterization of Amyloid β-Derived Diffusible LigandsRobert W. Hepler, Joseph G. Joyce, Paul M. Keller et al.|Biochemistry|2006Cited by 183